Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Production of recombinant mouse beta-interferon.

T Tanaka, M Naruto, G Kawano

    Journal of Interferon Research
    |August 1, 1986
    PubMed
    Summary

    Researchers engineered Escherichia coli to produce mouse beta-interferon (IFN-beta) using a modified tryptophan promoter. This achieved significant antiviral activity, demonstrating successful recombinant protein expression in bacteria.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Pharmacokinetics of dexmedetomidine combined with therapeutic hypothermia in a piglet asphyxia model.

    Acta anaesthesiologica Scandinavica·2014
    Same author

    Determinants of outcomes following acute child encephalopathy and encephalitis: pivotal effect of early and delayed cooling.

    Archives of disease in childhood·2010
    Same author

    Formulation and evaluation of lactoferrin bioadhesive tablets.

    International journal of pharmaceutics·2007
    Same author

    Single cell reporter assay using cell surface displayed Vargula luciferase.

    Journal of bioscience and bioengineering·2005
    Same author

    Engineering of functional chimeric protein G-Vargula luciferase.

    Analytical biochemistry·1997
    Same author

    Injection time of interleukin-6 determines fatal outcome in experimental endotoxin shock.

    Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research·1996

    Area of Science:

    • Biotechnology
    • Molecular Biology
    • Microbial Fermentation

    Background:

    • Interferons (IFNs) are crucial cytokines involved in antiviral responses.
    • Efficient and scalable production of therapeutic proteins like IFN-beta is essential.
    • Recombinant DNA technology offers a pathway for producing mammalian proteins in microbial hosts.

    Purpose of the Study:

    • To develop a system for expressing mouse beta-interferon (IFN-beta) in Escherichia coli.
    • To optimize conditions for high-level production of bioactive IFN-beta.
    • To assess the functional antiviral activity of the produced IFN-beta.

    Main Methods:

    • Construction of a recombinant plasmid for mouse IFN-beta expression.
    • Utilizing a modified tryptophan (trp) promoter for inducible expression in E. coli.
    • Cultivation of engineered E. coli in a minijar fermentor system.

    Main Results:

    • Successful expression of mouse IFN-beta in E. coli.
    • Achieved a high yield of antiviral activity, reaching up to 2.7 x 10^6 IU/ml.
    • Observed cellular morphological changes (elongation and curvature) in E. coli post-cultivation.

    Conclusions:

    • The engineered E. coli system is capable of producing biologically active mouse IFN-beta.
    • The modified trp promoter effectively drives IFN-beta expression in E. coli.
    • Further studies may explore the implications of cellular morphology changes on protein production.

    Related Experiment Videos